Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)
China
· Delayed Price · Currency is CNY 7.77
+0.05 (0.65%)
Apr 24, 2025, 2:45 PM CST
SHE:300434 Revenue
Sichuan Goldstone Asia Pharmaceutical had revenue of 234.72M CNY in the quarter ending September 30, 2024, with 21.40% growth. This brings the company's revenue in the last twelve months to 1.14B, down -16.16% year-over-year. In the year 2023, Sichuan Goldstone Asia Pharmaceutical had annual revenue of 1.21B, down -2.69%.
Revenue (ttm)
1.14B
Revenue Growth
-16.16%
P/S Ratio
2.74
Revenue / Employee
580.42K
Employees
1,962
Market Cap
3.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.21B | -33.40M | -2.69% |
| Jan 1, 2023 | 1.24B | 189.10M | 17.95% |
| Jan 1, 2022 | 1.05B | 276.21M | 35.53% |
| Dec 31, 2020 | 777.30M | -228.31M | -22.70% |
| Dec 31, 2019 | 1.01B | 34.89M | 3.59% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Contemporary Amperex Technology | 366.95B |
| Beijing-Shanghai High-Speed Railway | 42.16B |
| China State Construction Engineering Corporation | 2,187.15B |
| S.F. Holding | 284.42B |
| CRRC Corporation | 246.46B |
| NARI Technology | 55.28B |
| Shenzhen Inovance Technology Co.,Ltd | 35.70B |
| Sany Heavy Industry Co.,Ltd | 78.38B |